Feb 04, 2021

Notice Regarding the Difference of Individual Financial Results as Compared to Actual Results for the Previous Year

Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
Chairman & CEO: Tatsuro Kosaka
Inquiries to: Toshiya Sasai
Head of Corporate Communications Dept.
Tel:+81-(0)3-3273-0554

TOKYO, February 4, 2021-- Chugai Pharmaceutical Co., Ltd. announced that there is a difference regarding the individual financial results (Japanese standard) for the year ended December 2020 (Jan. 1, 2020– Dec. 31, 2020) as compared to the actual results for the previous year (Jan. 1, 2019 – Dec. 31, 2019).

1. Difference between the actual results for the year ended December 2020 and the actual results for the previous year

RevenuesOperating IncomeOrdinary IncomeNet IncomeEarnings per
Share*
Actual results for the previous year (A)
(Jan. 1, 2019 – Dec. 31, 2019)
(millions of yen)
678,591
(millions of yen)
203,921
(millions of yen)
208,296
(millions of yen)
155,584
(Yen Sen)
94.74
Actual results for this year (B)
(Jan. 1, 2020 – Dec. 31, 2020)
(millions of yen)
779,194
(millions of yen)
288,109
(millions of yen)
290,823
(millions of yen)
207,795
(Yen Sen)
126.44
Change (B-A) (millions of yen)
100,603
(millions of yen)
84,188
(millions of yen)
82,527
(millions of yen)
52,211
-
Change (%) 14.8 41.3 39.6 33.6 -

*Effective July 1, 2020, Chugai has implemented a three-for-one stock split of its common stock. “Earnings per share” are calculated based on the assumption that the stock split was implemented at the beginning of the previous year.

2. Reasons for the difference occurring
The difference occurred mainly due to increase in exports to Roche, increase in royalties and other operating income, and improvement in cost to sales ratio due to changes in product mix, etc.

Contact:

  • For Media
  • Chugai Pharmaceutical Co., Ltd.
  • Media Relations Group, Corporate Communications Dept.,
  • Tomoko Shimizu
  • Tel: +81-3-3273-0881
  • E-mail: pr@chugai-pharm.co.jp
  • For Investors
  • Chugai Pharmaceutical Co., Ltd.
  • Investor Relations Group, Corporate Communications Dept.,
  • Takayuki Sakurai
  • Tel: +81-3-3273-0554
  • E-mail: ir@chugai-pharm.co.jp
  • Like
  • Tweet
  • LINE it!
  • E-mail
Back to top